Ireland’s pharmaceutical and medical technology industries have experienced remarkable workforce expansion over the past six years, with employment numbers jumping 60% between 2019 and 2025, according to newly released figures from the Central Statistics Office. The accompanying wage bill for these sectors nearly doubled during the same period, increasing by 98%.
The statistics underscore the continued importance of life sciences manufacturing to Ireland’s economy, reflecting both organic growth within existing facilities and new foreign direct investment in the sector.
Key facts
- Employment in pharmaceutical and medical technology sectors rose 60% from 2019 to 2025
- Total wage expenditure increased by 98% over the six-year period
- Data compiled and released by the Central Statistics Office on 24 September 2026
- Growth period spans from 2019 through 2025
Workforce Expansion Reflects Sector Strength
The substantial employment increase demonstrates the pharmaceutical and medtech industries’ expanding footprint across Ireland. The 60% rise in personnel represents thousands of additional positions created throughout the country, particularly in established hubs where multinational corporations maintain significant manufacturing and research operations.
The even steeper 98% climb in wage expenditure suggests companies are not only hiring more workers but also competing for skilled talent with increasingly attractive compensation packages. This wage growth outpacing employment growth indicates rising salary levels across the sector, likely reflecting tight labour market conditions and the specialised expertise required for pharmaceutical manufacturing and medical device production.
Economic Implications for Ireland
The pharmaceutical and medical technology sectors represent cornerstone industries for Ireland’s economic strategy, contributing substantially to export revenues and tax receipts. The workforce expansion documented by the CSO reinforces Ireland’s position as a European hub for life sciences manufacturing, with numerous global pharmaceutical giants and medical device manufacturers maintaining operations across the country.
The dramatic wage bill increase also signals growing economic activity that extends beyond direct employment figures. Higher wages typically translate into increased consumer spending, residential demand in manufacturing centres, and enhanced tax revenues for the exchequer through income tax and Universal Social Charge collections.
These sectors have historically demonstrated resilience during economic downturns, and the continued investment in personnel suggests confidence among multinational corporations about Ireland’s long-term attractiveness as a manufacturing base. Factors including a skilled workforce, favourable regulatory environment, and established supply chains continue to draw pharmaceutical and medtech investment to Irish shores.
The CSO’s latest employment data arrives as Ireland continues to position itself competitively within the European pharmaceutical manufacturing landscape, with agencies such as IDA Ireland actively courting additional foreign direct investment in high-value manufacturing sectors.
Reporting based on original coverage by the original source.
